1.Jia F,Deng F,Xu P,Li S,Wang X,Hu P,Ren H,Tong S,Yin W（2021）NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes. Front Immunol 12（IF: 7.59）
2.Pan Qingbo,Qin Fanbo,Yuan Hanyu,He Baoning,Yang Ni,Zhang Yitong, Ren Hong,Zeng Yi, Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo‐related genes in hepatocellular carcinoma. Cancer Medicine, 2021. 10(9): p. 3139-3152.（IF=4.452）
3.Shen W,Ren H,TaxonKit: A practical and efficient NCBI taxonomy toolkit. Journal of Genetics and Genomics. 2021 Sep 20;48(9):844-850. (IF: 4.275)
4.Wang JJ,Wu CX,Wang YY,Chen CX,Cheng J,Rao XL,Sun H (corresponding author)，The Role of HMGB1 in Invasive Candida albicans Infection，Mycopathologia，2021，186（6）：789-805. (IF: 2.574)
5.He JH,Sun H (co-first author),Li F,Yang H,Lou MG,Wang SD,Wu CX，Efficacy and safety of raltitrexed-based transcatheter arterial chemoembolization for intermediate and advanced hepatocellular carcinoma: A multicenter real-world study，Hepatol Res， 2021，51（11）:1153-1163.（IF: 4.288）
6.Shao N, Cheng JM, Huang H, Gong XS,Lu YL,Idris M,Peng X,Ong BX, Zhang QY,Xu F,Liu CG. GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2. Cell Death Dis 2021; 12(3):253 (IF=8.469)
7.Ren P,Li H,Huang Y,Jiang J,Guo S,Cao Z,Zhang C,Zhou T,Gan Q,Zhao S, Chen L，Guo Q,Cai W,Wang H,Hu P,Xie Q. （2021）A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China. Antiviral Res. 2021 Oct;194:105163.（IF：5.970）
8.Tang Q,Wei L, Liu X, Hu P（2021）.Sofosbuvir-Based Therapies Achieved Satisfactory Virological Response in Chinese Individuals with Genotypes 3 and 6 Infections: A Real-World Experience.. Infect Drug Resist. 2021 Jun 21;14:2297-2307.（4.003）
9.Liu X, Hu P.（2021）Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection. J Clin Transl Hepatol. 2021 Feb 28;9(1):125-132. Epub 2021 Jan 18.（IF：4.108）
10.Zhang Q, Hu P. Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease. J Clin Transl Hepatol. Published online: May 7, 2021.（IF：4.108）
11.Wang CR, Zhong GC, Chen ZW,Hu P (2021) A nomogram for predicting non-rebound in HBV-infected pregnant women with mother-to-child transmission prevention. Front Med (Lausanne).8:746759.（IF：5.093）
12.Duan Y,Chen Z,Li H,Shen W,Zeng Y,Peng M,Hu P（2021）Potential molecular targets of tenofovir disoproxil fumarate for alleviating chronic liver diseases via a non-antiviral effect in a normal mouse model.Front Mol Biosci.（IF：5.246）
13. Liu Z,Jin Q,Zhang Y,Gong G,Wu G,Yao L,Wen X,Gao Z,Huang Y,Yang D,Chen E,Mao Q,Lin S,Shang J,Gong H,Zhong L,Yin H,Wang F,Hu P,Xiao L,Li C,Wu Q,Sun C,Niu J,Hou J; TMF Study Group.（2021）Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B. Aliment Pharmacol Ther.54(9):1134-1149 (IF:8.171)
14.Zhang J, Ling N, Lei Y, Peng M, Hu P and Chen M. (2021) Multifaceted Interaction Between Hepatitis B Virus Infection and Lipid Metabolism in Hepatocytes: A Potential Target of Antiviral Therapy for Chronic Hepatitis B. Front Microbiol.2021,12:636897. (IF:5.64)
15.Pan Z,Zhao R,Shen Y,Liu K,Xue W,Liang C,Peng M,Hu P,Chen M,Xu H.(2021) Low-frequency, exhausted immune status of CD56dim NK cells and disordered inflammatory cytokine secretion of CD56bright NK cells associated with progression of severe HFMD, especially in EV71-infected patients.Int Immunopharmacol.2021;101(Pt B):108369.(IF:4.932)
16.Zhou Y, He Y，Chang Y,Peng X,Zhao R, Peng M, Hu P, Ren H, Chen M, Xu H. (2021) The Characteristics of Natural Killer Cells and T Cells Vary With the Natural History of Chronic Hepatitis B in Children. Front. Pediatr. 9:736023. (IF:3.418)
17.Huang, WQ;Sun, H; Hu,T; Zhu,DJ; Long,XL;Guo, H;Liu, Q*.Blocking the short isoform of augmenter of liver regeneration inhibits proliferation of human multiple myeloma U266 cells via the MAPK/STAT3/cell cycle signaling pathway. ONCOLOGY LETTERS. 21(3):197（IF：2.311 ）
18.Qian Zhang,Da-Chuan Cai,Peng Hu,Hong Ren. （2021）Low-level viremia in nucleoside analog-treated chronic hepatitis B patients. Chin Med J (Engl). 134(23):2810-2817.（IF：2.6）
19.Shuang Xiao, Yanhong Deng, Neng Shen, Yong Sun, Huadong Tang, Peng Hu, Hong Ren, Mingli Peng. Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug. Int Immunopharmacol. 101(Pt A):108166.（IF：4.932）
20.Yi He, Yingzhi Zhou, Huimin Wang, Jingyang Yin, Yunan Chang, Peng Hu, Hong Ren, Hongmei Xu（2021）.Identifying potential biomarkers in hepatitis B virus infection and its response to the antiviral therapy by integrated bioinformatic analysis. J Cell Mol Med. 25(14):6558-6572.（IF：5.31）
21.Chao Zhou,Zhengyu Shi,Nan Ouyang and Xiongzhong Ruan. Hyperphosphatemia and Cardiovascular Disease. Frontiers in Cell and Developmental Biology. 2021 March 04;9:644363 (IF=6.684)
22.Zhou C, He Q, Gan H, Zeng T, Liu Q, Moorhead JF, Varghese Z, Ouyang N, Ruan XZ. Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans. Kidney Int. 2021 Feb 22:S0085-2538(21)00188-5. (IF=10.612)
23.Yu T,Zheng E,Li Y,Li Y,Xia J,Ding Q,Hou Z,Ruan XZ,Zhao L,Chen Y. Src-mediated Tyr353 phosphorylation of IP3R1 promotes its stability and causes apoptosis in palmitic acid-treated hepatocytes. Exp Cell Res. 2021 Feb 15;399(2):112438. (IF=3.905)
24.Lin Z,Gong J,Zhong G,Hu J,Cai D,Zhao L,Zhao Z. Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma. Front Oncol. 2021 May 14;11:666847. (IF=6.244)
25.Li Z,Li D,Rao Y,Wei L,Liu M,Zheng G,Yao Y,Hou X,Chen Y，Ruan XZ. SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth. Biomed Pharmacother. 2021 Jan;133:111011. (IF= 6.529)
26.Hu J,Wei XY,Xiang J,Peng P,Xu FL,Wu K,Luo FY,Jin AS,Fang L,Liu BZ, Wang K,Tang N, Huang AL（2021）Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera, Genes Dis. 2021 Dec 3. Epub ahead of print. (IF 7.103)
27.Liu R,Gou D,Xiang J,Pan X,Gao Q,Zhou P,Liu Y,Hu J,Wang K,Tang N.（2021）O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis. Oncogene 2021 Oct 14.（IF 9.867）
28.Peng P, Deng H , Hu J, Wei X, Xue J, Li T, Fang L, Liu B, Jin A, Xu F, Wu K, Long Q, Chen J, Wang K, Tang N, Huang AL.（2021）Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine. Cell Discov 2021 Aug 17; 7(1):68.（IF 10.849）
29.Wang K, Long QX, Deng HJ, Hu J, Gao QZ, Zhang GJ, He CL, Huang LY, Hu JL, Chen J, Tang N, Huang AL. （2021） Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection. Clin Infect Dis. 2021 Aug 2; 73(3):e531-e539.（IF 9.079）
30.Wang Q, Cheng B, Xue Q, Gao Q, Huang A, Wang K, Tang N（2021）GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis. Cell Death Dis. 2021, Apr 30; 12(5):426.（IF 8.469）
31.Xiang J, Chen C, Liu R, Gou D, Chang L, Deng H, Gao Q, Zhang W, Tuo L, Pan X, Liang L, Xia J, Huang L, Yao K, Wang B, Hu Z, Huang A, Wang K, Tang N（2021）. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. J Clin Invest. 2021 Apr 15;131(8):144703.（IF 14.808）
32.Xiao N, Nie M, Pang H, Wang B, Hu J, Meng X, Li K, Ran X, Long Q, Deng H, Chen N, Li S, Tang N, Huang AL, Hu Z. （2021）Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat Commun 2021 Mar 12; 12(1):1618.（IF 14.919）
33.He CL, Huang LY, Wang K, Gu CJ, Hu J, Zhang GJ, Xu W, Xie YH，Tang N, Huang AL.（2021） Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products. Signal Transduct Tar 2021 Mar 23; 6(1):131.（IF 18.187）
34.Hu J, Peng P, Wang K, Fang L, Liu BZ, Tang N, Huang AL.（2021）Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies. Cell Mol Immunol 2021 Apr; 18(4):1061-1063.（IF 11.53，共同通讯作者）
35.Peng P, Hu J, Deng HJ, Liu BZ, Fang L, Wang K*, Tang N*, Huang AL*, （2021）Changes of Humoral Immunity Response in SARS-CoV-2 Convalescent Patients over 8 months. Cell Mol Immunol 2021 Feb; 18(2):490-491.（IF 11.53）
36.Hu J, Gao QZ, Yang Y, Xia J, Zhang WJ, Chen Y, Zhou Z, Chang L, Hu Y, Zhou H, Liang L, Li XS, Long QX, Wang K*, Huang AL,Tang N.（2021）. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing OGT-meditated protein O-GlcNAcylation. Theranostics 2021 Jan 1; 11(2):805-823.（IF 11.556）
37.Han X, Wang Y, Li S, Hu C, Huang AL,Tang N, Jin A*. A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2. Front Immunol 2021 Mar 22; 12:653189. (IF 7.561)
38. Xin Xu,Sheng Nie,Yanqun Wang,Quanxin Long,Hong Zhu,Xiaoyong Zhang,Jian Sun,Qinglang Zeng,Jincun Zhao,Li Liu,Ling Li,Ailong Huang,Jinlin Hou,Fan Fan Hou（2021）Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study. Signal Transduct Target Ther.6(1):197.（IF：18.187）
39.Hong-Zhong Zhou,Fan Li,Sheng-Tao Cheng,Yong Xu ,Hai-Jun Deng ,Da-Yong Gu,Jin Wang, Wei-Xian Chen ,Yu-Jiao Zhou,Min-Li Yang ,Ji-Hua Ren ,Lu Zheng ,Ai-Long Huang,Juan Chen （2021）DDX17-regulated alternative splicing that produced a novel oncogenic isoform of PXN-AS1 to promote HCC metastasis. Hepatology. Online ahead of print.（IF：17.425）
40.Jiaxin Zheng,Yingying Deng,Zhenyu Zhao,Binli Mao,Mengji Lu,Yong Lin,Ailong Huang (2021) Characterization of SARS-CoV-2-Specific Humoral Immunity and Its Potential Applications and Therapeutic Prospects. Cell Mol Immunol.(IF:11.53)
41.Yi Wang,Yannan Zhao,Jiangling Wu,Ming Li,Juan Tan,Wensheng Fu,Hua Tang,Pu Zhang（2021）Negatively Charged Sulfur Quantum Dots for Treatment of Drug-Resistant Pathogenic Bacterial Infections. Nano Lett. 21(22):9433-9441.（IF：11.18）
42.Quan-Xin Long,Yan-Jun Jia,Xin Wang,Hai-Jun Deng,Xiao-Xia Cao,Jun Yuan,Liang Fang,Xu-Rong Cheng,Chao Luo,An-Ran He,Xiao-Jun Tang,Jie-Li Hu,Yuan Hu,Ni Tang,Xue-Fei Cai,De-Qiang Wang,Jie Hu,Jing-Fu Qiu,Bei-Zhong Liu,Juan Chen,Ai-Long Huang.Immune memory in convalescent patients with asymptomatic or mild COVID-19. Cell Discov. 7(1):18.（IF：10.849）
43.Yabin Zhang,Hao Sun,Rongjuan Pei,Binli Mao,Zhenyu Zhao,Huihui Li,Yong Lin,Kefeng Lu.（2021）The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes. Cell Discov. 7(1):31.（IF：10.849）
44.Zhujun Ai,Min Zhao,Daobin Han,Ke Chen,Dongmei Xiong,Hua Tang（2021）An “on-off” electrochemiluminescence immunosensor for PIVKA-II detection basedon the dual quenching of CeO2-Au-g-C3N4 hybrids by Ag nanocubes-VB2. Biosens Bioelectron. 179:113059.（IF：10.6）
45.Zhenyu Zhao,Kefeng Lu,Binli Mao,Shi Liu,Mirko Trilling,Ailong Huang,Mengji Lu,Yong Lin.（2021）The interplay between emerging human coronavirus infections and autophagy. Emerg Microbes Infect. 10(1):196-205.（IF：7.163）
46.Hai-Bo Yu,Sheng-Tao Cheng,Fang Ren,Yong Chen,Xiao-Feng Shi,Vincent Kam Wai Wong,Betty Yuen Kwan Law,Ji-Hua Ren,Shan Zhong,Wei-Xian Chen,Hong-Mei Xu,Zhen-Zhen Zhang,Jie-Li Hu,Xue-Fei Cai,Yuan Hu,Wen-Lu Zhang,Quan-Xin Long,Lin He,Zhong-Wen Hu,Hui Jiang,Hong-Zhong Zhou,Ai-Long Huang,Juan Chen（2021）SIRT7 restricts HBV transcription and replication through catalyzing desuccinylation of histone H3 associated with cccDNA minichromosome. Clin Sci (Lond). 135(12):1505-1522（IF：6.12）
47.Chun-Yang Gan,Jing Cui,Wen-Lu Zhang,Yu-Wei Wang,Ai-Long Huang,Jie-Li Hu（2021）DNA Engineering and Hepatitis B Virus Replication. Front Microbiol.12:783040.（IF：5.64）
48.Wen Wang,Shifeng Huang,Chunhong Zou,Yanhui Ding,Huijuan Wang,Shuli Pu,Yunfeng Liao,Hong Du,Deqiang Wang,Liang Chen,Siqiang Niu（2021）In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing
Enterobacterales. Front Cell Infect Microbiol.11:755763.（IF：5.29）
49.Junye Liu,Lulu Xia,Shilei Wang,Xuefei Cai,Xiaoli Wu,Chunhong Zou,Baoju Shan,Miao Luo,Deqiang Wang（2021）E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3.J Cancer.2021 Jun 22;12(17):5173-5180.（IF：4.207）
50.Yi Liang,Yao Fan,Yu Liu,Hui Fan.（2021）HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription. Exp Cell Res. 409(1):112898.（IF：3.905）
51.Zhen-Zhen Zhang,Da-Peng Chen,Quan-Bo Liu,Chuan Gan,Li Jiang,Kun Zhu,Xia-Yi Zhang,Hong-Mei Xu,Ai-Long Huang,Quan-Xin Long,Hai-Jun Deng,Juan Chen（2021） Clinical features of Chinese children with COVID-19 and other viral respiratory infections. Pediatr Pulmonol.57(1):49-56.（IF：3.039）
52.Zhuo Wang,YanMeng Chen,Haijun Deng,Xiaochuan Zhen,Jing Xiong,Yuan Hu.（2021）Quantification of intrahepatic cccDNA in HBV associated hepatocellular carcinoma by improved ddPCR method. J Virol Methods.299:114334. （IF：2.1）
53.Zhao L, Li Y, Ding Q, Li Y, Chen Y, Ruan XZ. CD36 Senses Dietary Lipids and Regulates Lipids Homeostasis in the Intestine. Front Physiol. 2021 Apr 28;12:669279. (IF=4.566)
54.Luo X, Zheng E, Wei L, Zeng H, Qin H, Zhang X, Liao M, Chen L, Zhao L, Ruan XZ, Yang P, Chen Y. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis Cell Death Dis. 2021 Mar 26;12(4):328. (IF=8.469)
55.Li, JJ;Xiong, C;Xu,P;Luo, Q;Zhang, RG.Puerarin induces apoptosis in prostate cancer cells via inactivation of the Keap1/Nrf2/ARE signaling pathway. BIOENGINEERED. 12: 402-413.（IF：2.205）
56.Li D,Liu M,Li Z,Zheng G,Chen A,Zhao L,Yang P,Wei L,Chen Y,Ruan XZ. Sterol-resistant SCAP overexpression in vascular smooth muscle cells accelerates atherosclerosis by increasing local vascular inflammation through activation of the NLRP3 inflammasome in mice. Aging and disease. 2021 Jun 12 (3) : 747-763. (IF=6.745)
57.Wang M, Xiong H, Chen H, Li Q, Ruan XZ. Renal Injury by SARS-CoV-2 Infection: A Systematic Review. Kidney Dis (Basel). 2021 Mar;7(2):100-110. (IF=3.222)